• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶和内毒素对犬体内抗凝血酶III(AT III)代谢的影响。

Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs.

作者信息

Tanaka H, Kobayashi N, Maekawa T

出版信息

Thromb Res. 1985 Nov 1;40(3):291-306. doi: 10.1016/0049-3848(85)90265-8.

DOI:10.1016/0049-3848(85)90265-8
PMID:4082111
Abstract

Effect of thrombin and endotoxin on the metabolism of I-125-labelled canine AT III was studied in mongrel dogs. Under control condition, mean total amount of intravascular AT III with standard deviation was 23.4 +/- 2.4 mg/kg, plasma half life of i.v. injected I-125-AT III was 1.7 +/- 0.2 days, and the fractional catabolic flux (j3x) was 16.3 +/- 1.6 mg/kg/day. The total amount of intra- and extra-vascular AT III was 36.0 +/- 0.34 mg/kg. Neither a 3 hour infusion of a small dose (30 units/kg/hr) of thrombin nor i.v. injection of a large amount of thrombin (5,000-15,000 units/day) with heparin significantly affected AT III metabolism except for a transient decrease in AT III concentration in the latter case, although decrease in plasma fibrinogen concentration and platelet count was observed in both cases. Two injections with 200 micrograms/kg of endotoxin resulted in an evident acceleration of AT III metabolism with significant decrease in the plasma AT III, fibrinogen concentrations and platelet count. More marked changes in AT III metabolism were induced by a single infusion with 1 mg/kg of endotoxin. Changes in hemostatic system coincided with those observed in DIC.

摘要

在杂种犬中研究了凝血酶和内毒素对I - 125标记的犬抗凝血酶III(AT III)代谢的影响。在对照条件下,血管内AT III的平均总量及其标准差为23.4±2.4mg/kg,静脉注射I - 125 - AT III的血浆半衰期为1.7±0.2天,分解代谢率(j3x)为16.3±1.6mg/kg/天。血管内和血管外AT III的总量为36.0±0.34mg/kg。小剂量(30单位/kg/小时)凝血酶3小时输注或与肝素一起静脉注射大量凝血酶(5000 - 15000单位/天)均未显著影响AT III代谢,只是在后一种情况下AT III浓度有短暂下降,尽管在两种情况下均观察到血浆纤维蛋白原浓度和血小板计数下降。两次注射200μg/kg内毒素导致AT III代谢明显加速,血浆AT III、纤维蛋白原浓度和血小板计数显著降低。单次输注1mg/kg内毒素诱导了更明显的AT III代谢变化。止血系统的变化与在弥散性血管内凝血(DIC)中观察到的变化一致。

相似文献

1
Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs.凝血酶和内毒素对犬体内抗凝血酶III(AT III)代谢的影响。
Thromb Res. 1985 Nov 1;40(3):291-306. doi: 10.1016/0049-3848(85)90265-8.
2
Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs.抗凝血酶III的生产研究,特别涉及犬内毒素诱导的弥散性血管内凝血。
Thromb Haemost. 1986 Oct 21;56(2):137-43.
3
In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.通过静脉注射凝血酶 - 肝素混合物在体内消耗抗凝血酶III的尝试。
Thromb Res. 1984 May 1;34(3):255-62. doi: 10.1016/0049-3848(84)90009-4.
4
A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.一种纯化的抗凝血酶III - 肝素复合物作为猪内毒素休克中凝血酶的有效抑制剂。
Thromb Res. 1991 Jan 1;61(1):1-10. doi: 10.1016/0049-3848(91)90163-q.
5
Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.人体内抗凝血酶III(肝素辅因子)的代谢:静脉血栓形成及肝素给药的影响。
Eur J Clin Invest. 1977 Feb;7(1):27-35. doi: 10.1111/j.1365-2362.1977.tb01566.x.
6
Further studies of the turnover of dog antithrombin III. Study of 131I-labelled antithrombin protease complexes.犬抗凝血酶III周转的进一步研究。131I标记的抗凝血酶蛋白酶复合物的研究。
Thromb Res. 1983 Apr 15;30(2):165-77. doi: 10.1016/0049-3848(83)90239-6.
7
Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.肝素、水蛭素及一种合成凝血酶抑制剂对大鼠凝血酶诱导的弥散性血管内凝血中抗凝血酶III的影响。
Haemostasis. 1987;17(6):321-8. doi: 10.1159/000215764.
8
The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.双结构域组织因子途径抑制剂对兔内毒素诱导的弥散性血管内凝血的影响。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):699-706.
9
Endotoxin-induced intravascular coagulation (DIC) and its therapy.内毒素诱导的血管内凝血(DIC)及其治疗。
Adv Shock Res. 1979;2:277-87.
10
Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin.
Thromb Haemost. 1984 Apr 30;51(2):232-5.

引用本文的文献

1
Platelet factor 4 (PF4) in septicaemia.败血症中的血小板因子4(PF4)
Infection. 1988 Sep-Oct;16(5):273-6. doi: 10.1007/BF01645070.
2
Clearance of thrombin in vivo: significance of alternative pathways.体内凝血酶的清除:替代途径的意义
Mol Cell Biochem. 1986 Aug;71(2):97-105. doi: 10.1007/BF00214768.
3
Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses.来自未用药或肝素化马匹的血浆中的抗凝血酶III活性(残余凝血酶活性)。
Vet Res Commun. 1989;13(1):31-46. doi: 10.1007/BF00366851.